propofol and Staphylococcal Infections
propofol has been researched along with Staphylococcal Infections in 9 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
" Following premedication with intramuscular midazolam and butorphanol, anesthesia was induced with propofol and maintained with sevoflurane by intubation." | 3.85 | ANESTHETIC MANAGEMENT OF AN INDO-PACIFIC BOTTLENOSE DOLPHIN (TURSIOPS ADUNCUS) REQUIRING SURGICAL DEBRIDEMENT OF A TAIL ABSCESS. ( Endo, Y; Izumisawa, Y; Koga, H; Tamura, J; Ueda, K; Yamashita, K; Yanagisawa, M, 2017) |
Research
Studies (9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Tamura, J | 1 |
Yanagisawa, M | 1 |
Endo, Y | 1 |
Ueda, K | 1 |
Koga, H | 1 |
Izumisawa, Y | 1 |
Yamashita, K | 1 |
Visvabharathy, L | 1 |
Freitag, NE | 1 |
Chen, MS | 1 |
Lin, WC | 1 |
Yeh, HT | 1 |
Hu, CL | 1 |
Sheu, SM | 1 |
Squair, JW | 1 |
Phillips, AA | 1 |
Harmon, M | 1 |
Krassioukov, AV | 1 |
Kuehnert, MJ | 1 |
Webb, RM | 1 |
Jochimsen, EM | 1 |
Hancock, GA | 1 |
Arduino, MJ | 1 |
Hand, S | 1 |
Currier, M | 1 |
Jarvis, WR | 1 |
Langevin, PB | 1 |
Gravenstein, N | 1 |
Doyle, TJ | 1 |
Roberts, SA | 1 |
Skinner, S | 1 |
Langevin, SO | 1 |
Gulig, PA | 1 |
Mehta, U | 1 |
Gunston, GD | 1 |
O'Connor, N | 1 |
Clinical Trials (4)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Restoring Hemodynamic Stability Using Targeted Epidural Spinal Stimulation Following Spinal Cord Injury[NCT04994886] | 8 participants (Anticipated) | Interventional | 2021-06-08 | Recruiting | |||
The Effects of Spinal Cord Stimulation on Autonomic Function in People With Spinal Cord Injury[NCT03924388] | 46 participants (Anticipated) | Interventional | 2020-02-01 | Not yet recruiting | |||
Restoring Hemodynamic Stability Using Targeted Epidural Spinal Stimulation Following Spinal Cord Injury[NCT05044923] | 8 participants (Anticipated) | Interventional | 2021-12-31 | Recruiting | |||
Epidural Electrical Stimulation to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury[NCT05111093] | 20 participants (Anticipated) | Interventional | 2021-11-29 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
9 other studies available for propofol and Staphylococcal Infections
Article | Year |
---|---|
ANESTHETIC MANAGEMENT OF AN INDO-PACIFIC BOTTLENOSE DOLPHIN (TURSIOPS ADUNCUS) REQUIRING SURGICAL DEBRIDEMENT OF A TAIL ABSCESS.
Topics: Abscess; Adjuvants, Anesthesia; Analgesics, Opioid; Anesthesia; Anesthetics, Inhalation; Animals; Bo | 2017 |
Propofol Sedation Exacerbates Kidney Pathology and Dissemination of Bacteria during Staphylococcus aureus Bloodstream Infections.
Topics: Animals; Bacteremia; Bacterial Load; Dendritic Cells; Disease Models, Animal; Disease Susceptibility | 2017 |
Propofol specifically suppresses IL-1β secretion but increases bacterial survival in Staphylococcus aureus-infected RAW264.7 cells.
Topics: Animals; Interleukin-1beta; Mice; Microbial Viability; Phagocytosis; Propofol; RAW 264.7 Cells; Reac | 2018 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Emergency management of autonomic dysreflexia with neurologic complications.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Autonomic Dysreflexia; Brain; Consc | 2016 |
Staphylococcus aureus bloodstream infections among patients undergoing electroconvulsive therapy traced to breaks in infection control and possible extrinsic contamination by propofol.
Topics: Aged; Aged, 80 and over; Anesthetics, Intravenous; Bacteremia; Cohort Studies; Drug Contamination; E | 1997 |
Growth of Staphylococcus aureus in Diprivan and Intralipid: implications on the pathogenesis of infections.
Topics: Anesthetics, Intravenous; Animals; Edetic Acid; Fat Emulsions, Intravenous; Kinetics; Propofol; Rabb | 1999 |
Serious consequences to misuse of propofol anaesthetic.
Topics: Anesthetics, Intravenous; Equipment Contamination; Humans; Klebsiella Infections; Klebsiella pneumon | 2000 |
Postsurgical infections associated with an extrinsically contaminated intravenous anesthetic agent--California, Illinois, Maine, and Michigan, 1990.
Topics: California; Candidiasis; Cluster Analysis; Drug Contamination; Equipment Contamination; Humans; Illi | 1990 |
Postoperative infections at Texas hospital prompt drug warning.
Topics: Anesthesia, Intravenous; Drug Contamination; Humans; Postoperative Complications; Propofol; Staphylo | 1990 |